Enhanced risk for recurrent adverse cardiovascular events in homozygous carriers of the T-allele of CD40 SNP rs1883832 [0.03%]
Mark Colin Gissler,Johannes Neumann,Linlin Guo et al.
Mark Colin Gissler et al.
Background and aims: The co-stimulatory signaling dyad of CD40 and CD40L is a potent inducer of cardiovascular inflammation and vulnerability of atherosclerotic plaques. A cytosine-to-thymidine transition (-1C > T) in the...
Karin Littmann,Daniel Eriksson Hogling,Mustafa Suhel et al.
Karin Littmann et al.
Background and aim: Elevated lipoprotein(a) [Lp(a)] contributes to coronary artery disease (CAD). This study aimed to determine the effectiveness of cascade screening for elevated Lp(a) in patients with CAD. ...
Johan Skov Bundgaard,Søren Albertsen Rand,Stefan Stender et al.
Johan Skov Bundgaard et al.
Background and aim: Both lipoprotein(a) [Lp(a)] and inflammation are independent causal risk factors for atherosclerotic cardiovascular disease (ASCVD). While previous studies have indicated that subclinical inflammation ...
Correspondence on: Impact of coronary artery disease patterns assessed with pullback pressure gradient on clinical outcomes: Meta-analysis [0.03%]
Artur Dziewierz,Barbara Zdzierak,Stanisław Bartuś et al.
Artur Dziewierz et al.
Corrigendum to "Characterization of lipoprotein (a) testing in Alberta, Canada: a retrospective cohort study" [Atherosclerosis 408, (2025) 120458] [0.03%]
Phongsack Manivong,Eileen Shaw,Tram Pham et al.
Phongsack Manivong et al.
Published Erratum
Atherosclerosis. 2026 Apr 27:417:120606. DOI:10.1016/j.atherosclerosis.2025.120606 2026
Preoperative proprotein convertase subtilisin/kexin type 9 inhibitors versus statins and postoperative adverse events in hyperlipidemia: A nationwide, active-comparator cohort study [0.03%]
Hsiang-Ling Wu,Jui-Tai Chen,Juan Pablo Cata et al.
Hsiang-Ling Wu et al.
Background and aims: Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors achieve substantial reductions in low-density lipoprotein cholesterol, yet their effectiveness and safety in the perioperative setting ...
Ling Li,Rainer Malik,Carla Abrahamian et al.
Ling Li et al.
Background and aims: Coronary artery disease (CAD), peripheral arterial disease (PAD), and ischemic stroke (IS) are the principal manifestations of atherosclerotic cardiovascular diseases (ASCVDs). Here we systematically ...
Association of the residual SYNTAX score on clinical outcomes in patients with acute coronary syndrome [0.03%]
Taito Arai,Koshiro Sakai,Hiroyoshi Mori et al.
Taito Arai et al.
Background: The residual SYNTAX score (rSS) quantifies coronary artery disease extent following percutaneous coronary intervention (PCI) and predicts adverse outcomes. However, its relationship with plaque morphology in a...
Long-term trends in dyslipidemia prevalence, awareness, treatment, and control in the Middle East and North Africa: a meta-analysis of 116 representative surveys [0.03%]
Ehsaneh Taheri,Shirin Esmaeili,Saeed Hamidizadeh et al.
Ehsaneh Taheri et al.
Background and aims: Dyslipidemia is a major risk factor for cardiovascular disease. Trends in dyslipidemia prevalence have been poorly described in the Middle East and North Africa region (MENA). We evaluated the prevale...